Finance

Lists
4579:TYO
RaQualia Pharma Inc
624,00 JP¥
+0,65%
(+4,00) 1D
1 қаз., 14:17:07 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4579...
Open
620 JP¥
High
625 JP¥
Low
606 JP¥
Mkt. cap
16,24 млрд
Avg. vol.
149,44 м.
Volume
86,20 мың
P/E ratio
109,68
52-wk high
1 465 JP¥
52-wk low
438 JP¥
EPS
6 JP¥
Shares outstanding
20,39 млн
No. of employees
85
Open
620 JP¥
High
625 JP¥
Low
606 JP¥
Mkt. cap
16,24 млрд
Avg. vol.
149,44 м.
Volume
86,20 мың
P/E ratio
109,68
52-wk high
1 465 JP¥
52-wk low
438 JP¥
EPS
6 JP¥
Shares outstanding
20,39 млн
No. of employees
85
News stories
From web sources and news partners
About RaQualia Pharma Inc
CEO-
Employees85
Founded2008 ж. 19 ақп.
Headquarters-
SectorPharmaceutical industry
Websiteraqualia.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
775,05 млн
1,67 млрд
801,99 млн
653,01 млн
Cost of goods sold
158,07 млн
164,78 млн
180,90 млн
159,10 млн
Cost of revenue
158,07 млн
164,78 млн
180,90 млн
159,10 млн
Research and development expenses
454,60 млн
362,13 млн
477,03 млн
383,97 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
316,93 млн
21,32 млн
304,26 млн
288,74 млн
Operating expense
771,53 млн
675,45 млн
781,29 млн
672,71 млн
Total operating expenses
929,60 млн
840,23 млн
962,19 млн
831,81 млн
Operating income
-154,55 млн
827,74 млн
-160,20 млн
-178,80 млн
Other non operating income
11,07 млн
-34,76 млн
-22,22 млн
17,22 млн
EBT including unusual items
-135,24 млн
863,66 млн
-158,72 млн
-167,28 млн
EBT excluding unusual items
-135,24 млн
837,66 млн
-158,72 млн
-156,28 млн
Income tax expense
78,99 млн
21,68 млн
66,97 млн
73,03 млн
Effective tax rate
-58,41%
2,51%
-42,19%
-43,66%
Other operating expenses
-
-
-
-
Net income
-214,24 млн
841,98 млн
-225,69 млн
-240,31 млн
Net profit margin
-27,64%
50,48%
-28,14%
-36,80%
Earnings per share
-
-
-
-
Interest and investment income
5,64 млн
11,40 млн
15,65 млн
8,35 млн
Interest expense
-14,75 млн
-14,07 млн
-15,16 млн
-15,84 млн
Net interest expenses
-9,10 млн
-2,67 млн
490,00 м.
-7,49 млн
Depreciation and amortization charges
-
7,00 млн
-
-
EBITDA
-33,70 млн
956,64 млн
-48,80 млн
-65,20 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары